Release date: 2014-09-02 The Israeli company ReWalk Robotics is coming soon, and the company has developed exoskeleton devices that help the deaf to walk, bringing new hope to those who have lost leg mobility. ReWalk Robotics announced on Wednesday (August 27) that it will be listed on the NASDAQ within 30 days. The initial public offering of 3.4 million shares worth $14-16 is expected to raise $50 million. Based on these data, the market value of ReWalk is estimated to be nearly $200 million. Last month, the ReWalk system was approved by the US Food and Drug Administration to allow it to enter the market as an exoskeleton system that helps the deaf. The ReWalk system was licensed by the European Union at the end of 2012. After obtaining approval from the US Food and Drug Administration, ReWalk said that the number of potential customers for consultation has increased significantly. ReWalk said in a listing statement issued to Nasdaq that as of August 1, 81 exoskeleton systems have been sold. ReWalk allows users to walk independently and control their pace, just like people with normal limbs. Through computers and motion sensors, ReWalk can control motion by detecting subtle changes in the position of the center of gravity, mimic the natural pace, and provide the user with the appropriate walking speed so that the quadriplegic can walk independently. Users can even run a marathon, and a woman who is in a hurry can do it in 2012. The system has been tested in Israel, the United States and Europe for a long time. Some people involved in the ReWalk test phase project have started using the device. Clinical studies have shown that in addition to providing the wearer with the ability to stand and walk independently, ReWalk can also give the user a mental health belt as the user gains a more positive self-image in the process of gaining independence and being able to control their actions. Come a lot of benefits. In addition, studies have shown that ReWalk can improve cardiovascular health, reduce adipose tissue, strengthen muscles, and improve bowel function. Rewalk users say that since the system was used, their pain has decreased, the amount of medication used has decreased, and the number of hospital visits has decreased. US President Barack Obama personally evaluated the ReWalk system when he visited Israel in 2013. The system was exhibited at a special exhibition entitled “Israeli Technology for a Better Worldâ€. The exhibition, held at the Israel Museum, highlights Israel's seven most important technical contributions. The inventor of the system was Amit Goffer. The Israeli inventor suffered quadriplegia after an all-terrain vehicle accident in 1997. Through his personal experience, Goffer developed sports equipment for people suffering from spinal cord injuries and later invented ReWalk. “It’s people who use the system to walk, not the system to use people to walk.†Goff said, “Users have control and they can decide when to sit, stand and walk.†For users of ReWalk, running a marathon is not impossible. In 2012, Claire Lomas, who was paralyzed below the chest, ran a marathon at the London Paralympics. It took her 17 days to finish the marathon – but she knew she had been unable to walk for five years since she was injured in a horse riding accident. It is very difficult for her to complete this run and even start running. "Running the London Marathon seems like a night of talk," Lomas said. "This is not what people expect from a person wearing ReWalk. Walking in the room is one thing, walking after 12 days of training. 26 miles is another thing. I have never hesitated about this. The thing I did was to take every step. I took a step closer to the finish line every step." Source: Israel Times Led Curing Devices,Led Light Curing,Led Light Curing Machine,Led Curing Device Rolence Enterprise Inc. , https://www.rolencedent.com
US President Barack Obama personally evaluated the ReWalk system when he visited Israel in 2013, and the company announced on Wednesday (August 27) that it will be listed on the NASDAQ within 30 days. The initial public offering of 3.4 million shares worth $14-16 is expected to raise $50 million.